Bayer’s Purchase Of Schering AG Creates $4.5 Bil. Diagnostics Company
Bayer's purchase of Schering AG will add imaging agents to the firm's diagnostics portfolio and boost testing-related revenue by roughly two-thirds to $4.5 bil. annually
Bayer's purchase of Schering AG will add imaging agents to the firm's diagnostics portfolio and boost testing-related revenue by roughly two-thirds to $4.5 bil. annually